期刊文献+

p63蛋白在乳腺良恶性上皮性病变中的表达及意义 被引量:1

Role of p63 in differential diagnosis of epithelial benign and malignant breast lesions
在线阅读 下载PDF
导出
摘要 目的:探讨p63在乳腺良、恶性疾病中的表达及意义。方法:收集乳腺良、恶性疾病的石蜡包埋标本50例(纤维腺瘤,纤维囊性病,导管内乳头状瘤,导管内癌,浸润性导管癌和浸润性小叶癌)采用免疫组化S-P法检测p63在上述病变中的表达。结果:在乳腺良性病变中几乎所有的腺体外周都见完整的p63阳性的肌上皮围绕;在导管内癌中,部分导管外围可见完整的p63阳性的肌上皮围绕(24%),部分导管外周p63阳性的肌上皮细胞则呈间断性分布(62%),甚至无肌上皮细胞(14%);在浸润性癌的癌细胞巢外周未见p63阳性的肌上皮细胞。结论:p63作为肌上皮细胞的标记物有助于在疑难的乳腺病变中正确识别肌上皮细胞,鉴别良恶性病变。 Objective :To study the role of p63 in differential diagnosis of epithelial benign and malignant breast lesions. Methods: We collected 50 eases of breast benign and malignant paraffin-embedded samples(ineluding fibroadenoma ,fibrocystie diseases, intraduetal papilloma,intraduetal eaieinoma,invasive duetal carcinoma and invasive lobular eareinoma),and detected the expression of p63 in above breast lesions by immunohistoehemistry.Results:In breast benign lesions, almost all of the glands were encircled by p63 positive cells. In intraduetal carcinoma,some cancer cell nests(24%) showed continuous positive cells in their circumference;other showed discontinuous or even no positive cells (62% and 14% respectively) .There were no p63 positive cells in invasive carcinomas. Concluslon:As a marker of myoepithelial ceUs,p63 could help to recognize myoepithelial cells correctly in confusing breast lesions and differentiate epithelial benign from malignant breast lesions.
出处 《现代医药卫生》 2007年第22期3341-3342,共2页 Journal of Modern Medicine & Health
关键词 乳腺疾病 免疫组织化学 P63 Breast disease Immunohistochemistry P63
  • 相关文献

参考文献7

  • 1Papotti M, Eusebi V, Gugliotta P,et al. Immunohistochemical analysis of benign and malignant papillary lesions of the breast[J]. Am J Surg Pathol, 1993,7:451.
  • 2Tannishtha R,Sean J,Micheal F,et al. Stem ceils cancer and cancer stem cells[J].Nature,2001,414(3):105.
  • 3Barbareschi M,Pecciarini L,Cangi MG,et al. P63,a p53 homologue, is a selective nuclearmarker of myoepithelial cells of the human breast[J]. Am J Surg Pathol, 2001,25:1054.
  • 4Werling RW, Hwang H ,Yaziji H ,et al. Immunohistochemical distinction of invasive from noninvasive breast lesions[J]. Am J Surg Pathol, 2003,27(1):82.
  • 5卢晓梅,陈书媛,张淑红.p63显示肌上皮细胞在乳腺癌诊断中价值[J].临床与实验病理学杂志,2004,20(1):35-38. 被引量:21
  • 6Batistatou A, Stefanou D,Arkoumani E, et al. The usefulness of p63 as a marker of breast myoepithelial cells[J]. In vivo,2003,17(6):573.
  • 7ML,Hyjek E,Giri DD ,et al. Double immunolabling with cytokeratin and smooth muscle actin in confirming early invasive carcinoma of breast[J].Am J Surg, 1999,23:176.

二级参考文献4

  • 1[1]Nayar R, Breland C, Bedrossian U,et al. Immunoreactivity of ductal cells with putative myoepithelial markers: A potential pitfall in breast carcinoma. Ann Diagn Pathol, 1999,3(3): 165~73.
  • 2[2]Wang X, Mori I, Tang W,et al. p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer, 2002,9(3):216~9.
  • 3[3]Werling RW, Hwang H, Yaziji H,et al. Immunohistochemical distinction of invasive from noninvasive breast lesions:A comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol, 2003,27(1):82~90.
  • 4[4]Ribeiro-Silva A, Zamzelli Ramalho LN, Garcia SB, et al. Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast? Pathol Oncol Res, 2003,9(1): 20~3.

共引文献20

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部